BiotechTubeBiotechTube
Home/Aspen Pharmacare/Kuseni Dlamini
KD

Kuseni Dlamini

Independent Non-executive Director, Board Chair

Aspen Pharmacare

Therapeutic Areas

AnaestheticsThrombosisOncologyAutoimmune DiseasesPediatric NutritionGeneral Medicine

Aspen Pharmacare Pipeline

DrugIndicationPhase
Anaesthetics PortfolioPerioperative careApproved
Thrombosis Portfolio (e.g., Arixtra® generics)Prevention/treatment of blood clotsApproved
High Potency & Cytotoxic SterilesOncology & supportive careApproved
Biosimilars (e.g., trastuzumab, rituximab)Oncology, Autoimmune diseasesApproved
Infant NutritionalsPediatric nutritionApproved
General OTC & Prescription BrandsVarious (Pain, Allergy, GI)Approved

Leadership Team at Aspen Pharmacare

SS
Stephen Saad
Group Chief Executive
SC
Sean Capazorio
Group Chief Financial Officer
RH
Reginald Haman
Executive Director (Group Enablement)
BK
Ben Kruger
Lead Independent Non-executive Director
LD
Linda de Beer
Independent Non-executive Director
ND
Neo Dongwana
Independent Non-executive Director
TM
Themba Mkhwanazi
Independent Non-executive Director
CM
Chris Mortimer
Independent Non-executive Director
YM
Yvonne Muthien
Independent Non-executive Director
DR
David Redfern
Independent Non-executive Director
View full Aspen Pharmacare profile